News
08-03-2021, 07:13 AM
The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology's Elenagen, an experimental DNA therapy, to include two new arms: 1) hormone-resistant breast cancer; and 2) hormone-resistant metastatic prostate cancer.
More... (https://www.news-medical.net/news/20210803/Hormone-resistant-prostate-breast-cancers-added-to-clinical-trial-of-experimental-DNA-therapy.aspx)
More... (https://www.news-medical.net/news/20210803/Hormone-resistant-prostate-breast-cancers-added-to-clinical-trial-of-experimental-DNA-therapy.aspx)